Grow Everything Biotech Podcast

Doug Friedman joins the podcast to talk about one of the toughest challenges in biotech—how to survive long enough to actually make an impact. As the head of BioMADE, he's on a mission to build a bioindustrial manufacturing ecosystem that doesn’t just rely on wishful thinking and a single grant check. He explains why most biotech startups get only "one shot on goal" (spoiler: they mi...

Noah Helman, co-founder of Industrial Microbes, unpacks how his team is giving ethanol a glow-up as a renewable feedstock for creating advanced polymers and sustainable carbon fibers. With a decade of experience in the trenches of biomanufacturing, Noah discusses how they’re engineering microbes to work smarter, not harder, tackling the challenges of cost, scale, and environmental impact. From lev...

Erum and Karl have an incredible chat with Nick Edwards, the innovative mind behind Potato AI. Nick goes into the inspiration behind the platform's unique name, rooted in childhood curiosity and scientific wonder, and shares his journey from neuroscience research to building a groundbreaking tool aimed at accelerating scientific discovery. He explains how Potato tackles the overwhelming deluge...

Karl and Erum welcome Dr. Chris Mason. He’s a professor of genomics, physiology, and biophysics, as well as co-founder / COI of BiotiaNYC, Ursa Bio, and Onegevity. Chris will take you on a journey from the mysteries of space genomics to the hidden worlds of Earth's microbiomes. He discusses the intersection of advanced biology and space exploration, diving into his work with NASA’s twin study, the...

Karl and Erum give us a peek into their outlook for 2025, discussing biotech trends, the rise of decentralized science, and the convergence of AI with biology. They talk about the thawing of the "biotech winter," the potential risks of a new bird flu pandemic, and exciting innovations in quantum biology and drug discovery. Their conversation also touches on how waste can become a resource in bioma...

Karl and Erum welcome Niklas Anzinger, the visionary founder of Vitalia, a decentralized city aimed at revolutionizing biotech and longevity. Niklas discusses the need for a more efficient drug development process, proposing a shift toward safety trials and medical reciprocity that could drastically shorten the time it takes to bring life-saving therapies to market. He talks about how Vitalia serv...

Kevin Flyangolts joins Erum and Karl to talk about the evolving landscape of biosecurity. They discuss the rapid advancements in biotechnology, the growing accessibility of synthetic DNA, and the need for robust screening systems to ensure safety in the bioeconomy. Kevin shares knowledge from his software background, explaining how tools like those at Aclid Bio are bridging gaps in security, prote...

Andy Bass brings the ocean's glow to your hands, turning natural wonders like bioluminescent plankton into personal and immersive experiences. From creating the Dino Pet to designing ocean-bathing exhibits, Andy shares how biology can light up creativity, spark curiosity, and inspire the next generation of conservationists. It's a conversation about the intersection of nature, imagination, and the...

Karl and Erum are taking us deep into the intersection of biology, industry, and innovation with their guest, Jason Kakoyiannis. Jason is the founder of Bioscentric, advisor at Allonnia, and managing partner of Ferment! From starting his journey in the art world to leading the charge at Ferment, Jason shares how curiosity and the drive to solve complex problems led him to build a venture studio fo...

Join Karl and Erum in this special Thanksgiving replay of Aaron Schacht’s episode as they revisit this fascinating conversation. Aaron is the CEO & Board Director of BiomEdit and he has a visionary approach to leveraging microbiome science and synthetic biology to tackle some of the biggest challenges in animal health. Whether it’s creating healthier livestock, addressing sustainability issues...

Karl and Erum welcome computational biologist and artist Elizabeth Henaff to talk about the invisible yet vital world of microbiomes in urban settings. Elizabeth discusses the fascinating interplay between microbes and city life, explaining how DNA sequencing brings out hidden microbial stories in spaces like subway stations, waterways, and even beehives. The conversation goes into how design deci...

Karl and Erum bring on Dr. Alexander Titus, a commissioner on the National Security Commission on Emerging Biotechnology, to explore the exciting and challenging intersections of biotechnology and policy. Alexander shares his experiences from his unique journey across academia, government, and industry, diving into the role of biosecurity, the potential of synthetic biology, and the emerging conve...

Karl and Erum sit down with Moji Karimi, co-founder of Cemvita, a company innovating in carbon conversion technology. Moji shares details of Cemvita’s journey from an ambitious vision of industrial biotechnology to solutions that turn carbon emissions into valuable products. Moji talks about the science and impact of reshaping industries like energy, mining, and aerospace, pointing out how importa...

Rocky Graziose from The Estée Lauder Companies is here to discuss the innovative intersection of biotechnology and beauty. With a background in plant natural products chemistry, Rocky brings an insider perspective on how Estée Lauder is pushing boundaries in skincare and cosmetics. He talks about the evolution of the beauty industry and how The Estée Lauder’s Companies commitment to sustainability...

In this milestone 100th episode, Karl and Erum look back on collaborations like the biosecurity event with Andrew Hessel and the U.S.-India Next Gen Materials event, while also acknowledging the establishment of the Chumash Heritage National Marine Sanctuary. Erum and Karl are also joined by special guest Dan Grushkin to explore the evolving world of biotechnology and its impact on society. They t...

Erum and Karl reflect on their journey of producing nearly 100 episodes over two years. They discuss the challenges of consistency, the behind-the-scenes work required, and the evolution of their podcast from a simple idea to a platform that amplifies voices in the biotech space. Highlights include their gratitude to guests and collaborators, feedback from listeners, and the growing impact of thei...

Yuji Suzuki shares his journey from economics to leading a biotech company at the forefront of microbial research. He explains how bitBiome is unlocking the potential of trillions of microbes using advanced sequencing technology, and how their work could reshape industries from pharmaceuticals to sustainability. Yuji also dives into the future of biotechnology, the challenges of working with micro...

Karl and Erum are taking us into the world of biohacking, discussing its various definitions and practices, from simple lifestyle changes to more extreme measures like genetic modification. They dig into the growing movement toward improving health, longevity, and human performance, touching on biohacking pioneers like Brian Johnson. Their conversation includes insights on the ethical and societal...

Karl and Erum welcome Christina Smolke, CEO of Antheia and Professor at Stanford University, to discuss the rapid changes happening in biotech, particularly focusing on the biohacking community and decentralized science (DCI). Christina is developing revolutionary ways to manufacture critical pharmaceuticals using biotechnology. They explore the intersection of biohacking, pharmaceuticals, and eme...

Christina Agapakis from Ginkgo Bioworks joins the conversation to explore the power of storytelling in science. She goes into the challenges scientists face when communicating their work to the public and the role effective messaging plays in shaping perceptions, especially around complex topics like GMOs and synthetic biology. Christina shares her journey and insights from her time at Ginkgo, and...

Erum and Karl sit down with Vega Shah from NVIDIA to explore the role of AI in healthcare and life sciences, and how it's driving major advances in drug discovery and biotechnology. Vega shares real-world examples, from lab-grown cotton to using AI to discover new proteins in the gut microbiome. She also discusses the challenges of modeling complex biological systems and how tools like generat...

Astronaut and molecular biologist Dr. Kate Rubins shares her groundbreaking work on the International Space Station, from being the first to conduct DNA sequencing in space to advancing biotechnology in a unique and challenging environment. Dr. Rubins explains how space affects biological processes, the tools being developed to study these effects, and how these advancements could revolutionize in...

Eben Bayer, founder of Ecovative, delves into the transformative power of mycelium technology and its potential to reshape industries from packaging to food production. He shares his journey from a small farm in Vermont to leading a company that pioneers sustainable materials, discussing how biology can be leveraged to create regenerative, profitable businesses. With a strong belief in the power o...

Karl and Erum dig into the pivotal role of bio strategy in shaping the future of consumer products and sustainability. With insights into groundbreaking innovations—from Cresalon's trauma gel gaining FDA approval to Living Ink's partnership with New Balance—this discussion explores how biotech is transforming traditional industries. We also tackle the challenges of scaling bio-manufacturin...

Episode Description: Erum and Karl welcome Deniz Kent to talk about the practical and innovative ways light is being used to control cellular processes, offering new possibilities in biotechnology. From sustainable fashion to the future of biomanufacturing, they discuss topics that impact both our personal lives and the broader scientific community. Deniz shares insights on using light-sensitive p...